|
This innovative benchmarking program describes in detail the strategies
that leading pharmaceutical companies use to achieve preferred formulary
status for their key drugs, including:
 |
Organizing and deploying the managed markets sales force |
 |
Evaluating and training the managed markets sales force |
 |
Sales negotiation strategies/tactics |
The report provides comprehensive analysis of each target organization's
strategic approach to managed markets, including:
1. Strategic approach
to the managed care marketplace
 |
Overall sales strategy |
 |
Descriptions of programs / services offered to
managed care organizations
 |
Formulary compliance initiatives
|
 |
Physician / consumer education programs
|
 |
Disease management |
 |
Other |
|
 |
How key managed care functions fit into the overall
corporate structure |
 |
Deployment of the managed markets sales force
segmented by type of account
 |
National |
 |
Regional |
 |
Government |
 |
Employer |
 |
Other |
|
2. Organizational
strategy for managed market initiatives
 |
Educational and professional backgrounds of key
personnel |
 |
Evaluation methods for key personnel |
 |
Training program |
 |
Compensation of managed care sales representatives |
This one-of-a-kind report captures the
responses of over 100 practicing oncologists in the United States – as
they are asked to rate the effectiveness of leading oncology sales
forces in regard to the following attributes:
 | Product knowledge |
 | Disease-state knowledge |
 | Competitor product knowledge |
 | Sampling frequency |
 | Responsiveness to the needs of the
doctor’s practice |
 | Call frequency |
 | Trustworthiness |
 | And other pertinent areas… |
We not only capture the revealing survey
results, but PharmaForce digs deeper by conducting targeted interviews
with members of the “best” and “worst” performing sales forces to
uncover the reasons for their rankings.
This program analyzes in detail the marketing expenditures of leading
oncology franchises in the top five countries in Europe (i.e., France,
Germany, Italy, Spain and the United Kingdom). The key expenditures
benchmarked include:
 |
Major conventions |
 |
Representative-initiated physician education programs
|
 |
Clinical trials for approved products |
 |
Advocacy/cooperative group grants
|
 |
CME programs |
 |
Journal advertisements |
 |
Printed sales materials |
Analysis of the sales and marketing organizations includes:
 |
Size and structure of the oncology sales force
|
 |
How the oncology product portfolio is managed
|
 |
Organizational structure of oncology sales and
marketing management |
 |
Deployment of other oncology-related field personnel,
such as medical liaisons |
 |
Role of oncology medical liaisons
|
 |
Qualifications and compensation of oncology sales
personnel, including typical salary/bonus ratios
|
* Save 5% -- Mention "PharmCast.com" when
purchase.
To receive more information about the study,
please click on the
following "Request for Info" link.
|